Chronic lung disease in HIV-infected children established on antiretroviral 1 therapy 2
暂无分享,去创建一个
S. Rowland-Jones | G. McHugh | H. Mujuru | R. Ferrand | J. Metcalfe | J. Rylance | K. Nathoo | E. Majonga | S. Wilmore | 4. Katharina | Kranzer
[1] J. Reynes,et al. Immune activation in the course of HIV‐1 infection: Causes, phenotypes and persistence under therapy , 2016, HIV medicine.
[2] A. Morris,et al. Maintaining lung health with longstanding HIV , 2016, Current opinion in infectious diseases.
[3] S. Anderson,et al. Clinical Characteristics and Lung Function in Older Children Vertically Infected With Human Immunodeficiency Virus in Malawi , 2015, Journal of the Pediatric Infectious Diseases Society.
[4] Anand K. Gupta,et al. Non Cystic Fibrosis Bronchiectasis , 2015, The Indian Journal of Pediatrics.
[5] R. Salamon,et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. , 2015, The New England journal of medicine.
[6] L. Ferreyra-Reyes,et al. A Novel Scoring System to Measure Radiographic Abnormalities and Related Spirometric Values in Cured Pulmonary Tuberculosis , 2013, PloS one.
[7] L. Myer,et al. A Systematic Review of the Association between Pulmonary Tuberculosis and the Development of Chronic Airflow Obstruction in Adults , 2013, Respiration.
[8] R. Gie,et al. The challenge of chronic lung disease in HIV-infected children and adolescents , 2013, Journal of the International AIDS Society.
[9] R. Ferrand,et al. Cardiac Disease in Adolescents With Delayed Diagnosis of Vertically Acquired HIV Infection , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] J. Hankinson,et al. MULTI-ETHNIC REFERENCE VALUES FOR SPIROMETRY FOR THE 3–95 YEAR AGE RANGE: THE GLOBAL LUNG FUNCTION , 2013 .
[11] Gundo Weiler,et al. Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .
[12] A. Wells,et al. Chronic Lung Disease in Adolescents With Delayed Diagnosis of Vertically Acquired HIV Infection , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] V. Varavithya,et al. Pretreatment and posttreatment radiography in patients with pulmonary tuberculosis with and without human immunodeficiency virus infection , 2011, Japanese Journal of Radiology.
[14] B. Richardson,et al. Post-HAART Outcomes in Pediatric Populations: Comparison of Resource-Limited and Developed Countries , 2011, Pediatrics.
[15] M. King,et al. Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. , 2009, The Journal of infectious diseases.
[16] H. Zar. Chronic lung disease in human immunodeficiency virus (HIV) infected children , 2008, Pediatric pulmonology.
[17] H. So,et al. Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years. , 2007, American journal of respiratory and critical care medicine.
[18] Paige L. Williams,et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. , 2006, JAMA.
[19] Hirofumi Tanaka,et al. Age-predicted maximal heart rate revisited. , 2001, Journal of the American College of Cardiology.
[20] P. Jeena,et al. Persistent and chronic lung disease in HIV‐1‐infected and uninfected African children , 1998, AIDS.
[21] M. Sharland,et al. Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection , 1997, Archives of disease in childhood.